P2X4 receptors of microglia in neuropathic pain

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 6, 2012, Pages 699-704

  Inoue, Kazuhide ^a   Tsuda, Makoto ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Microglia; Neuropathic pain; P2X4Rs

Indexed keywords

2?3? (2,4,6 TRINITROPHENYL) ADENOSINE 5? TRIPHOSPHATE; ANTICONVULSIVE AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; FLUVOXAMINE; GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; PAROXETINE; PLATELET DERIVED GROWTH FACTOR; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X4 RECEPTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ALLODYNIA; ARTICLE; CELL ACTIVATION; EXOCYTOSIS; HUMAN; MICROGLIA; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SPINAL GANGLION;

ANIMALS; CHEMOKINE CCL21; HUMANS; MICROGLIA; MOLECULAR TARGETED THERAPY; NEURALGIA; PERIPHERAL NERVE INJURIES; RECEPTORS, PURINERGIC P2X4; SPINAL CORD; UP-REGULATION;

EID: 84869061119     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712803581065     Document Type: Article

References (68)

1. Baron, R. Mechanisms of disease: neuropathic pain--a clinical perspective. Nat. Clin. Pract. Neurol., 2006, 2(2), 95-106.
2. Woolf, C.J.; Mannion, R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet, 1999, 353(9168), 1959-1964.
3. Scholz, J.; Woolf, C.J. Can we conquer pain? Nat. Neurosci., 2002, 5(Suppl), 1062-1067.
4. Woolf, C.J.; Salter, M.W. Neuronal plasticity: increasing the gain in pain. Science, 2000, 288(5472), 1765-1769.
5. Costigan, M.; Scholz, J.; Woolf, C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci., 2009, 32, 1-32.
6. Watkins, L.R.; Milligan, E.D.; Maier, S.F. Glial activation: a driving force for pathological pain. Trends Neurosci., 2001, 24(8), 450-455.
7. Tsuda, M.; Inoue, K.; Salter, M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci., 2005, 28(2), 101-107.
8. Marchand, F.; Perretti, M.; McMahon, S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci., 2005, 6(7), 521-532.
9. Scholz, J.; Woolf, C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci., 2007, 10(11), 1361-1368.
10. Suter, M.R.; Wen, Y.R.; Decosterd, I.; Ji, R.R. Do glial cells control pain? Neuron Glia Biol., 2007, 3(3), 255-268.
11. Davalos, D.; Grutzendler, J.; Yang, G.; Kim, J.V.; Zuo, Y.; Jung, S.; Littman, D.R.; Dustin, M.L.; Gan, W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci., 2005, 8(6), 752-758.
12. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308(5726), 1314-1318.
13. Echeverry, S.; Shi, X.Q.; Zhang, J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain, 2008, 135(1-2), 37-47.
14. Tsuda, M.; Shigemoto-Mogami, Y.; Koizumi, S.; Mizokoshi, A.; Kohsaka, S.; Salter, M.W.; Inoue, K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 2003, 424(6950), 778-783.
15. Jin, S.X.; Zhuang, Z.Y.; Woolf, C.J.; Ji, R.R. p38 mitogenactivated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci., 2003, 23(10), 4017-4022.
16. Tsuda, M.; Mizokoshi, A.; Shigemoto-Mogami, Y.; Koizumi, S.; Inoue, K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia, 2004, 45(1), 89-95.
17. Tanga, F.Y.; Nutile-McMenemy, N.; DeLeo, J.A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. USA, 2005, 102(16), 5856-5861.
18. Zhuang, Z.Y.; Gerner, P.; Woolf, C.J.; Ji, R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain, 2005, 114(1-2), 149-159.
19. Obata, K.; Katsura, H.; Mizushima, T.; Sakurai, J.; Kobayashi, K.; Yamanaka, H.; Dai, Y.; Fukuoka, T.; Noguchi, K. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J. Neurochem., 2007, 102(5), 1569-1584.
20. Clark, A.K.; Gentry, C.; Bradbury, E.J.; McMahon, S.B.; Malcangio, M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain, 2007, 11(2), 223-230.
21. Griffin, R.S.; Costigan, M.; Brenner, G.J.; Ma, C.H.; Scholz, J.; Moss, A.; Allchorne, A.J.; Stahl, G.L.; Woolf, C.J. Complement induction in spinal cord microglia results in anaphylatoxin C5amediated pain hypersensitivity. J. Neurosci., 2007, 27(32), 8699-8708.
22. Coull, J.A.; Beggs, S.; Boudreau, D.; Boivin, D.; Tsuda, M.; Inoue, K.; Gravel, C.; Salter, M.W.; De Koninck, Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 2005, 438(7070), 1017-1021.
23. Keller, A.F.; Beggs, S.; Salter, M.W.; De Koninck, Y. Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Mol. Pain, 2007, 3, 27.
24. Burnstock, G. Purinergic nerves. Pharmacol. Rev., 1972, 24(3), 509-581.
25. Lustig, K.D.; Shiau, A.K.; Brake, A.J.; Julius, D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA, 1993, 90(11), 5113-5117.
26. Webb, T.E.; Simon, J.; Krishek, B.J.; Bateson, A.N.; Smart, T.G.; King, B.F.; Burnstock, G.; Barnard, E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett., 1993, 324(2), 219-225.
27. Ralevic, V.; Burnstock, G. Receptors for purines and pyrimidines. Pharmacol. Rev., 1998, 50(3), 413-492.
28. Khakh, B.S.; Burnstock, G.; Kennedy, C.; King, B.F.; North, R.A.; Séguéla, P.; Voigt, M.; Humphrey, P.P. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev., 2001, 53(1), 107-118.
29. Abbracchio, M.P.; Burnstock, G.; Boeynaems, J.M.; King, B.F.; North, R.A.; Séguéla, P.; Voigt, M.; Humphrey, P.P. International Union of Pharmacology LVIII: update on the P2Y G proteincoupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev., 2006, 58(3), 281-341.
30. North, R.A. Molecular physiology of P2X receptors. Physiol. Rev., 2002, 82(4), 1013-1067.
31. Nicke, A.; Baumert, H.G.; Rettinger, J.; Eichele, A.; Lambrecht, G.; Mutschler, E.; Schmalzing, G. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J., 1998, 17(11), 3016-3028.
32. Stoop, R.; Thomas, S.; Rassendren, F.; Kawashima, E.; Buell, G.; Surprenant, A.; North, R.A. Contribution of individual subunits to the multimeric P2X(2) receptor: estimates based on methanethiosulfonate block at T336C. Mol. Pharmacol., 1999, 56(5), 973-981.
33. Nicke, A.; Rettinger, J.; Schmalzing, G. Monomeric and dimeric byproducts are the principal functional elements of higher order P2X1 concatamers. Mol. Pharmacol., 2003, 63(1), 243-252.
34. Jiang, L.H.; Kim, M.; Spelta, V.; Bo, X.; Surprenant, A.; North, R.A. Subunit arrangement in P2X receptors. J. Neurosci., 2003, 23(26), 8903-8910.
35. Shinozaki, Y.; Sumitomo, K.; Tsuda, M.; Schuichi Koizumi, Kazuhide Inoue, Keiichi Torimitsu. Direct Observation of ATPInduced Conformational Changes in Single P2X4 Receptors. PLoS Biol., 2009, 7(5), e103.
36. Kawate, T.; Michel, J.C.; Birdsong, W.T.; Gouaux, E. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature, 2009, 460(7255), 592-598.
37. Jarvis, M.F.; Khakh, B.S. ATP-gated P2X cation-channels. Neuropharmacology, 2009, 56(1), 208-215.
38. Ulmann, L.; Hatcher, J.P.; Hughes, J.P.; Chaumont, S.; Green, P.J.; Conquet, F.; Buell, G.N.; Reeve, A.J.; Chessell, I.P.; Rassendren, F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci., 2008, 28(44), 11263-11268.
39. Tsuda, M.; Kuboyama, K.; Inoue, T.; Nagata, K.; Tozaki-Saitoh, H.; Inoue, K. Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol. Pain, 2009, 5(1), 28.
40. Gauriau, C.; Bernard, J.F. Pain pathways and parabrachial circuits in the rat. Exp. Physiol., 2002, 87(2), 251-258.
41. Trang, T.; Beggs, S.; Wan, X.; Salter, M.W. P2X4-receptormediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci., 2009, 29(11), 3518-3528.
42. Inoue, K. Microglial activation by purines and pyrimidines. Glia, 2002, 40(2), 156-163.
43. Inoue, K. The function of microglia through purinergic receptors: Neuropathic pain and cytokine release. Pharmacol. Ther., 2006, 109(1-2), 210-226.
44. Reeve, A.J.; Patel, S.; Fox, A.; Walker, K.; Urban, L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur. J. Pain, 2000, 4(3), 247-257.
45. Viviani, B.; Bartesaghi, S.; Gardoni, F.; Vezzani, A.; Behrens, M.M.; Bartfai, T.; Binaglia, M.; Corsini, E.; Di Luca, M.; Galli, C.L.; Marinovich, M. Interleukin-1beta enhances NMDA receptormediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci., 2003, 23(25), 8692-8700.
46. Wang, S.; Cheng, Q.; Malik, S.; Yang, J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther., 2000, 292(2), 497-504.
47. Ikeda, H.; Tsuda, M.; Inoue, K.; Murase, K. Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn. Eur. J. Neurosci., 2007, 25(5), 1297-1306.
48. Kawasaki, Y.; Zhang, L.; Cheng, J.K.; Ji, R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci., 2008, 28(20), 5189-5194.
49. Zhao, P.; Waxman, S.G.; Hains, B.C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci., 2007, 27(9), 2357-2368.
50. Guo, L.H.; Guo, K.T.; Wendel, H.P.; Schluesener, H.J. Combinations of TLR and NOD2 ligands stimulate rat microglial P2X4R expression. Biochem. Biophys. Res. Commun., 2006, 349(3), 1156-1162.
51. Nasu-Tada, K.; Koizumi, S.; Tsuda, M.; Kunifusa, E.; Inoue, K. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X(4), a key molecule for mechanical allodynia. Glia, 2006, 53(769-775.
52. Tsuda, M.; Toyomitsu, E.; Kometani, M.; Tozaki-Saitoh, H.; Inoue, K. Mechanisms underlying fibronectin-induced upregulation of P2XR expression in microglia: distinct roles of PI3K-Akt and MEK-ERK signaling pathways. J. Cell. Mol. Med., 2009, 13(9b), 3251-3259.
53. Tsuda, M.; Toyomitsu, E.; Komatsu, T.; Masuda, T.; Kunifusa, E.; Nasu-Tada, K.; Koizumi, S.; Yamamoto, K.; Ando, J.; Inoue, K. Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia, 2008, 56(5), 579-585.
54. Tsuda, M.; Tozaki-Saitoh, H.; Masuda, T.; Toyomitsu, E.; Tezuka, T.; Yamamoto, T.; Inoue, K. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia, 2008, 56(1), 50-58.
55. Tsuda, M.; Masuda, T.; Kitano, J.; Shimoyamam, H.; Tozaki-Saitoh, H.; Inoue, K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc. Natl. Acad. Sci. USA, 2009, 106(19), 8032-8037.
56. Qureshi, O.S.; Paramasivam, A.; Yu, J.C.; Murrell-Lagnado, R.D. Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J. Cell Sci., 2007, 120(Pt 21), 3838-3849.
57. Toyomitsu, E.; Tsuda, M.; Yamashita, T.; Tozaki-Saitoh, H.; Tanaka, Y.; Inoue, K. CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia. Purinergic Signal., 2012, 8(2), 301-310.
58. Inoue, K.; Tsuda, M. Microglia and neuropathic pain. Glia, 2009, 57(14), 1469-1479.
59. Hanisch, U.K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10(11), 1387-1394.
60. Narita, M.; Usui, A.; Narita, M.; Niikura, K.; Nozaki, H.; Khotib, J.; Nagumo, Y.; Yajima, Y.; Suzuki, T. Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury. J. Neurosci., 2005, 25(43), 10000-10009.
61. Masuda, J.; Tsuda, M.; Tozaki-Saitoh, H.; Inoue, K. Intrathecal delivery of PDGF produces tactile allodynia through its receptors in spinal microglia. Mol. Pain, 2009, 5, 23.
62. Biber, K.; Sauter, A.; Brouwer, N.; Copray, S.C.; Boddeke, H.W. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia, 2001, 34(2), 121-133.
63. Rappert, A.; Biber, K.; Nolte, C.; Lipp, M.; Schubel, A.; Lu, B.; Gerard, N.P.; Gerard, C.; Boddeke, H.W.; Kettenmann, H. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl-current and chemotaxis in murine microglia. J. Immunol., 2002, 168(7), 3221-3226.
64. de Jong, E.K.; Dijkstra, I.M.; Hensens, M.; Brouwer, N.; van Amerongen, M.; Liem, R.S.; Boddeke, H.W.; Biber, K. Vesiclemediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J. Neurosci., 2005, 25(33), 7548-7557.
65. de Jong, E.K.; Vinet, J.; Stanulovic, V.S.; Meijer, M.; Wesseling, E.; Sjollema, K.; Boddeke, H.W.; Biber, K. Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles. FASEB J., 2008, 22(12), 4136-4145.
66. Biber, K.; Tsuda, M.; Tozaki-Saitoh, H.; Tsukamoto, K.; Toyomitsu, E.; Masuda, T.; Boddeke, H.; Inoue, K. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J., 2011, 30(9), 1864-1873.
67. Nagata, K.; Imai, T.; Yamashita, T.; Tsuda, M.; Tozaki-Saitoh, H.; Inoue, K. Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Mol. Pain, 2009, 5(20).
68. Toulme, E.; Garcia, A.; Samways, D.; Egan, T.M.; Carson, M.J.; Khakh, B.S. P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J. Gen. Physiol., 2010, 135(4), 333-353.